2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Synthesis of 3- O-sulfated oligosaccharides to understand the relationship between structures and functions of heparan sulfate

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The sulfation at the 3-OH position of glucosamine is an important modification in forming structural domains for heparan sulfate to enable its biological functions. Seven 3- O-sulfotransferase isoforms in the human genome are involved in the biosynthesis of 3- O-sulfated heparan sulfate. As a rare modification present in heparan sulfate, the availability of 3- O-sulfated oligosaccharides is very limited. Here, we report the use of a chemoenzymatic synthetic approach to synthesize six 3- O-sulfated oligosaccharides, including three hexasaccharides and three octasaccharides. The synthesis was achieved by rearranging the enzymatic modification sequence to accommodate the substrate specificity of 3- O-sulfotransferase 3. We studied the impact of 3- O-sulfation on the conformation of the pyranose ring of 2- O-sulfated iduronic acid using NMR, and on the correlation between ring conformation and anticoagulant activity. We identified a novel octasaccharide that interacts with antithrombin and displays anti factor Xa activity. Interestingly, the octasaccharide displays a faster clearance rate than fondaparinux, an FDA approved pentasaccharide drug, in a rat model, making this octasaccharide a potential short acting anticoagulant drug candidate that could reduce bleeding risk. Having access to a set of critically important 3- O-sulfated oligosaccharides offers the potential to develop new heparan sulfate-based therapeutics.

          TOC image

          Related collections

          Author and article information

          Journal
          7503056
          4435
          J Am Chem Soc
          J. Am. Chem. Soc.
          Journal of the American Chemical Society
          0002-7863
          1520-5126
          18 April 2017
          03 April 2017
          12 April 2017
          03 October 2018
          : 139
          : 14
          : 5249-5256
          Affiliations
          [1 ]Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
          [2 ]National Glycoengineering Research Center, Shandong University, Jinan 250100, China
          [3 ]Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA
          [4 ]School of Pharmacy, University College London, 29 39 Brunswick Square, London WC1N 1AX, UK
          [5 ]Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina, NC 27599, USA
          Author notes
          Correspondence and requests for materials should be addressed to J.L. ( jian_liu@ 123456unc.edu )
          [6]

          Both authors contributed equally to this work

          Article
          PMC5624809 PMC5624809 5624809 nihpa864307
          10.1021/jacs.7b01923
          5624809
          28340300
          aca008f3-c433-43a5-a260-0f3c6fbc0731
          History
          Categories
          Article

          Comments

          Comment on this article